Famotidine and Keratitis for Women aged 60+ (a phase IV clinical study of FDA data)

Summary:

Keratitis is found for women aged 60+ who take Famotidine (famotidine). This study is created by eHealthMe based on reports of 18,767 women aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Famotidine when people have Keratitis
Top conditions
Top co-used drugs
Top other side effects

On Apr, 15, 2026

18,767 women aged 60+ reported to have side effects when taking Famotidine.
Among them, 15 people (0.08%) have Keratitis

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,415 Famotidine users. Check the latest studies of Famotidine.

What is Keratitis?

Keratitis (eye's cornea, the front part of the eye, becomes inflamed) is found to be associated with 442 drugs and 832 conditions by eHealthMe. Check the latest studies of Keratitis.

Number of reports submitted per year:

Could Famotidine cause Keratitis in women aged 60+?

Time on Famotidine when people have Keratitis *

Severity of Keratitis

n/a

How people recovered from Keratitis

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Pain: 12 people, 80.00%
High Blood Pressure: 12 people, 80.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 12 people, 80.00%
Depression: 12 people, 80.00%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 6.67%
Keratitis Fungal (inflammation of the cornea due to fungal organism): 1 person, 6.67%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Zoloft: 12 people, 80.00%
Hydroxyurea: 12 people, 80.00%
Miacalcin: 12 people, 80.00%
Lotrel: 12 people, 80.00%
Lopressor: 12 people, 80.00%
Lisinopril: 12 people, 80.00%
Levalbuterol Hydrochloride: 12 people, 80.00%
Hydroxyzine: 12 people, 80.00%
Hydrea: 12 people, 80.00%
Norvasc: 12 people, 80.00%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Zollinger-Ellison Syndrome (increased production of the hormone gastrin from a small tumour of pancreas): 12 people, 80.00%
Fatigue (feeling of tiredness): 12 people, 80.00%
Ectropion (lower eyelid turns outwards): 12 people, 80.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 12 people, 80.00%
Enlarged Heart: 12 people, 80.00%
Extrasystoles: 12 people, 80.00%
Eye Injury: 12 people, 80.00%
Facial Bones Fracture (bone fracture of face): 12 people, 80.00%
Facial Pain: 12 people, 80.00%
Fall: 12 people, 80.00%

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and have Keratitis?

- Check whether Keratitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Famotidine and Keratitis

How the study uses the data?

The study is based on (applicable) gender, age, famotidine (the active ingredients of Famotidine) and Famotidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.